News
June 21, 2021•From Julie Gregory, Insider Strategies, News
Julie Gregory offers tips and planning strategies to stay on the protocol while traveling. Read More »
June 18, 2021•From Dr. Bredesen, News
Far Reaching Implications of the Aducanumab Debacle
Dr. Bredesen discusses the far reaching implications of the FDA’s controversial approval of the drug Aduhelm, rejected by its own independent advisory panel. Read More »
June 11, 2021•Facebook Live Videos, News, Past Events
Facebook Live: What Does Aducanumab Mean for Alzheimer’s?
Dr. Dale Bredesen and Julie Gregory discussed the FDA’s approval Biogen’s drug Aduhelm and the ramifications for those seeking treatment for Alzheimer’s. Read More »
June 9, 2021•News
Aducanumab vs. the ReCODE Protocol
The recently FDA approved Aduhelm did not improve cognition but mildly slowed down disease progression with dangerous side effects compared to the ReCODE Protocol, which in a recent trial demonstrated that 84% of the participants improved cognition with health optimization as the only side effect. Read More »
June 9, 2021•Interviews, News
FDA Approves New Alzheimer’s Drug Despite Little Evidence it Works
Dr. Bredesen speaks with CBN News’ reporter, Lorie Johnson, about the recent FDA approval of the Alzheimer’s drug Aduhelm. Read More »
June 7, 2021•From Ram Rao, Insider Strategies, News
The Ill Effects of Prolonged Sitting
Dr. Ram Rao discusses how prolonged sitting has serious detrimental effects on our bodies and health. Read More »
June 7, 2021•From Julie Gregory, Insider Strategies, News
Julie Gregory discusses the importance of stimulating the lymphatic system to upregulate our body’s ability to detoxify. Read More »
June 7, 2021•KetoFLEX 12/3 Kitchen, News, Nutrition, Recipes
KetoFLEX 12/3 Kitchen: ¡Viva la Mexico!
KetoFLEX 12/3 Kitchen: Celebrating the citrusy and bold flavors of Latin dishes such as a Kojito (mocktail), Rainbow Fajitas, and Ensalada Rustica. Read More »